Nippon India NIFTY Pharma ETF
Monthly portfolio · 24 months through May-2026
compared to Apr-2026 · as on May 31,2026
Holdings
20
Scheme AUM
₹1,570 cr
New
0
Exited
0
Increased
20
Reduced
0
| Change | Security | Industry / Rating | Quantity | Δ Qty | % to NAV | Δ % | Market value |
|---|---|---|---|---|---|---|---|
| Increased | Sun Pharmaceutical Industries Limited INE044A01036 | Pharmaceuticals & Biotechnology | 18,69,418 | +1,79,446 | 21.42% | -1.11pp | ₹336 cr |
| Increased | Divi's Laboratories Limited INE361B01024 | Pharmaceuticals & Biotechnology | 2,24,373 | +21,473 | 9.53% | -0.20pp | ₹150 cr |
| Increased | Dr. Reddy's Laboratories Limited INE089A01031 | Pharmaceuticals & Biotechnology | 10,75,921 | +1,03,372 | 8.93% | -0.56pp | ₹140 cr |
| Increased | Cipla Limited INE059A01026 | Pharmaceuticals & Biotechnology | 9,93,316 | +95,210 | 8.86% | +0.19pp | ₹139 cr |
| Increased | Lupin Limited INE326A01037 | Pharmaceuticals & Biotechnology | 4,28,234 | +40,994 | 6.18% | -0.40pp | ₹97.11 cr |
| Increased | Laurus Labs Limited INE947Q01028 | Pharmaceuticals & Biotechnology | 6,86,956 | +65,926 | 5.96% | +0.92pp | ₹93.56 cr |
| Increased | Torrent Pharmaceuticals Limited INE685A01028 | Pharmaceuticals & Biotechnology | 1,84,671 | +17,734 | 5.19% | +0.04pp | ₹81.45 cr |
| Increased | Aurobindo Pharma Limited INE406A01037 | Pharmaceuticals & Biotechnology | 4,93,546 | +47,342 | 4.48% | -0.09pp | ₹70.4 cr |
| Increased | Glenmark Pharmaceuticals Limited INE935A01035 | Pharmaceuticals & Biotechnology | 2,65,843 | +25,440 | 3.85% | -0.42pp | ₹60.48 cr |
| Increased | Alkem Laboratories Limited INE540L01014 | Pharmaceuticals & Biotechnology | 1,03,310 | +10,005 | 3.62% | -0.09pp | ₹56.8 cr |
| Increased | Biocon Limited INE376G01013 | Pharmaceuticals & Biotechnology | 12,60,096 | +1,20,761 | 3.44% | +0.42pp | ₹54.01 cr |
| Increased | Zydus Lifesciences Limited INE010B01027 | Pharmaceuticals & Biotechnology | 4,41,677 | +42,311 | 3.03% | +0.40pp | ₹47.6 cr |
| Increased | Mankind Pharma Limited INE634S01028 | Pharmaceuticals & Biotechnology | 1,99,769 | +19,129 | 3.02% | +0.03pp | ₹47.46 cr |
| Increased | IPCA Laboratories Limited INE571A01038 | Pharmaceuticals & Biotechnology | 2,45,210 | +23,606 | 2.38% | -0.12pp | ₹37.38 cr |
| Increased | Gland Pharma Limited INE068V01023 | Pharmaceuticals & Biotechnology | 1,40,517 | +13,424 | 2.01% | +0.37pp | ₹31.62 cr |
| Increased | JB Chemicals & Pharmaceuticals Limited INE572A01036 | Pharmaceuticals & Biotechnology | 1,44,528 | +13,802 | 2.00% | +0.03pp | ₹31.33 cr |
| Increased | Wockhardt Limited INE049B01025 | Pharmaceuticals & Biotechnology | 1,45,846 | +14,108 | 1.89% | +0.53pp | ₹29.63 cr |
| Increased | Abbott India Limited INE358A01014 | Pharmaceuticals & Biotechnology | 9,194 | +909 | 1.57% | +0.02pp | ₹24.69 cr |
| Increased | Ajanta Pharma Limited INE031B01049 | Pharmaceuticals & Biotechnology | 74,378 | +7,105 | 1.39% | -0.01pp | ₹21.78 cr |
| Increased | Piramal Pharma Limited INE0DK501011 | Pharmaceuticals & Biotechnology | 10,94,059 | +1,04,885 | 1.20% | +0.02pp | ₹18.9 cr |
Cash & other
| Triparty Repo | 0.46% | ₹7.18 cr |
| Cash Margin - CCIL | 0.00% | ₹0.03 cr |
| Net Current Assets | -0.41% | ₹-6.59 cr |